Dominic Eisinger, Ph.D.

Dominic Eisinger, Ph.D.

About Dominic Eisinger, Ph.D.

Vice President, Sales & Marketing Operations

Dr. Eisinger joined Rules-Based Medicine in 2006 as part of the business development management team. Prior to Myriad RBM, he was President and Director of Business Development at Multiplex Biosciences, a multiplex immunoassay development, validation and manufacturing services company he co-founded with Dr. Laurie Stephen. A noted international authority on immunoassay, he also started and directed Upstate Cell Signaling Solutions’ multiplex business unit from its inception in 2000 until 2006.